The role of adiponectin in cancer: a review of current evidence.

By Maria Dalamaga, K. Diakopoulos, C. Mantzoros. Endocrine reviews, 2012

618 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Oncology

View Paper: https://www.semanticscholar.org/paper/81f2f282f797eebcc8f92226e9711ff1ed0df788

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. J. Slingerland

Citations in the corpus

• Obesity and inflammation: the linking mechanism and the complications (2016, background): “[124] in a review linked it with many types of cancer based on epidemiological evidence.”
• Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention (2017, background): “In contrast, adiponectin is reduced in obesity, and this also constitutes a risk factor for postmenopausal breast cancer.(123,124)”
• Obesity and cancer risk: Emerging biological mechanisms and perspectives. (2019, background): “To date, more than 15 adipocytokines have been linked to cancer while their list is still growing [3,4,47,48].”